CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

Celldex’s mAb fails to show benefit in Phase II prurigo nodularis trial

Phase 2
Related Companies

Read the original article

Published by Clinical Trials Arena on July 22, 2026 10:21 AM

Read Original